Association of the T (-344) C polymorphism of aldosterone synthase gene CYP11B2 with essential hypertension in Xinjiang Kazakh isolated group

Chinese Journal of Medical Genetics

Volumn 21, Issue 6, 2004, Pages 622-624

  Xu, Xin Juan ^a   Wang, Shi Zhen ^a   Lin, Ren Yong ^a   Wang, Xiao Feng ^a   Liang, Xiao Hui ^a   Wen, Hao ^a   Zhang, Zhao Xia ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Aldosterone synthase gene; Gene polymorphism; Hypertension; Kazakh ethnic

Indexed keywords

ALDOSTERONE SYNTHASE; RESTRICTION ENDONUCLEASE;

ADULT; ARTICLE; CYP11B2 GENE; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; FEMALE; GENE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION;

ADULT; ALDOSTERONE SYNTHASE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CHINA; FEMALE; GENE FREQUENCY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX FACTORS; SPECIES SPECIFICITY;

EID: 10644288713     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. 2) C - 344T polymorphism in Caucasians from the Berlin Salt-Sensitivity Trial (BeSST). J Hypertens, 1999, 17: 1563-1567.
2. Pojoga L, Gautier S, Blanc H, et al. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens, 1998, 11: 856-860.
3. 2 gene polymorphism with genetic predisposition to essential hypertension. J Hum Hypertens, 2002, 16: 789-793.
4. Tiret L, Mellet C, Poirier O, et al. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol, 2000, 35: 29-35.
5. 2. Hypertension, 1999, 33: 703-707.
6. 2 gene and hypertension in Japanese. Hypertension, 1999, 33: 266-270.
7. 2) gene polymorphism and classic risk factors on risk of myocardial infarction. Circulation, 1999, 100: 2213-2218.
8. 2) polymorphism shows association with essential hypertension. J Hypertens, 2003, 21: 1331-1337.
9. 2) gene polymorphisms and left ventricular size, mass and function. Circulation, 1998, 97: 569-575.
10. Wang SZ, Zhang YM, Cheng ZH, et al. Study on hypertension epidemic in different ethnicpopulation in Xinjiang. Chin J Cardiol, 1984, 12: 179-182.
11. Zhao GS, Yuan XY, Wang SZ, et al. Nutrition metablism and hypertension-comparison study of nutritional parameter and blood pressure. Chin J Cardiol, 1986, 14: 8-12.
12. Zhang MT, Wang LT. The relationship between blood pressure and body growth in adolescents in Xinjiang. Chin J Cardiol, 1994, 22: 99-101.
13. Brand E, Chatelain N, Mulatero P, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension, 1998, 32: 198-204.
14. Zhang AH, Zhang WX, Tang XM, et al. The relationship of aldosterone synthase gene polymorphism with hypertension and left ventricular hypertrophy. Chin J Intern Med, 2002, 41: 298-301.
15. 2) in hypertension in China. Chin J Hypertens, 2003, 11: 238-240.
16. Bassett MH, Zhang Y, Clyne C, et al. Differential regulation of aldosterone synthase and 11 beta-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol, 2002, 28: 125-135.
17. Charchar FJ, Tomaszewski M, Padmanabhan S, et al. The Y chromosome effect on blood pressure in two European populations. Hypertension, 2002, 39: 353-356.
18. 2 polymorphisms and cardiovascular risk factors. J Hypertens, 2003, 21: 1249-1253.